Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.

about

Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial.

Item

http://www.wikidata.org/entity/Q41507036

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Vitamin D supplementation in c ...... a randomized controlled trial.

@en

type

Item

label

Vitamin D supplementation in c ...... a randomized controlled trial.

@en

prefLabel

Vitamin D supplementation in c ...... a randomized controlled trial.

@en

P1476

Vitamin D supplementation in c ...... a randomized controlled trial

@en

P2093

C Aura

http://www.w3.org/2001/XMLSchema#string

D Lambrechts

http://www.w3.org/2001/XMLSchema#string

D Vanderschueren

http://www.w3.org/2001/XMLSchema#string

G Emri

http://www.w3.org/2001/XMLSchema#string

J De Smedt

http://www.w3.org/2001/XMLSchema#string

K Vandenberghe

http://www.w3.org/2001/XMLSchema#string

M Garmyn

http://www.w3.org/2001/XMLSchema#string

M Stas

http://www.w3.org/2001/XMLSchema#string

O Bechter

http://www.w3.org/2001/XMLSchema#string

P Wolter

http://www.w3.org/2001/XMLSchema#string

P2860

Common genetic determinants of vitamin D insufficiency: a genome-wide association study

Cancer statistics, 2008

Final version of 2009 AJCC melanoma staging and classification

Melanoma--Part 1: epidemiology, risk factors, and prevention.

Epidemiology of melanoma.

Vitamin D and systemic cancer: is this relevant to malignant melanoma?

Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol.

Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).

Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein

Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.

P2888

s12885-017-3538-4

P304

562

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3538-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kris Bogaerts

Arjen Nikkels

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091328566

http://www.w3.org/2001/XMLSchema#string

P698

28835228

http://www.w3.org/2001/XMLSchema#string

P921

vitamin D

P932

5569491

http://www.w3.org/2001/XMLSchema#string